发明名称 AZABICYCLIC CARBOXAMIDE DERIVATIVES,PREPARATION THEREOF AND THEAPEUTIC USE THEREOF
摘要 Azabicyclic carboxamide compounds (I) and their acid or base addition salts, hydrates or solvates are new. Azabicyclic carboxamide compounds of formula (I) and their acid or base addition salts, hydrates or solvates are new. X 1-X 4N or CR 1; Z 1-Z 4N, C or CR 2; 2C+R aR b5-membered ring containing a nitrogen atom and carbon atoms, and optionally saturated and optionally substituted; W 1O or S; n : 0-3; Y 1aryl or heteroaryl; R 1e.g. H, halo, 1-6C alkyl, 3-7C cycloalkyl, 3-7C cycloalkyl-1-3C alkylene, 1-6C fluoroalkyl, aryloxy-1-6C alkyl or heteroaryloxy-1-6C alkyl; and R 2e.g. H, halo, 3-7C cycloalkyl-1-3C-alkylene-O-, OH, thiol or 1-6C fluoroalkoxy. Full Definitions are given in the DEFINITIONS (Full Definitions) Field. An independent claim is included for the preparation of (I). [Image] ACTIVITY : Analgesic; Antiinflammatory; Metabolic; Gynecological; Gastrointestinal-Gen.; Respiratory-Gen.; Antipsoriatic; Antipruritic; Virucide; Neuroprotective; Antidepressant; Antiarthritic; Osteopathic; Muscular-Gen.; Antimigraine; Vulnerary; Dermatological; Cerebroprotective; Vasotropic; Antidiabetic; Uropathic; Nephrotropic; Antiulcer; Antiasthmatic; Antitussive; CNS-Gen.; Antiallergic; Immunosuppressive. MECHANISM OF ACTION : Transient receptor potential vanilloid type 1 (TRPV1) receptor modulator. The ability of (I) to inhibit current induced by capsaicin was tested in primary cells of dorsal root ganglia (DRG) of rat. The result showed that N-(1H-pyrrolo[2,3-b]pyridin-5-yl)-5-fluoro-1-(3-fluorobenzyl)-1H-indole-2-carboxamide (1 nM) exhibited 82% inhibition in DRG patch.
申请公布号 ZA201005202(B) 申请公布日期 2011.09.28
申请号 ZA20100005202 申请日期 2010.07.21
申请人 SANOFI-AVENTIS 发明人 DUBOIS LAURENT;EVANNO YANNICK;MACHNIK DAVID;MALANDA ANDRE
分类号 C07D;A61K;A61P 主分类号 C07D
代理机构 代理人
主权项
地址